Covestor’s Kura Oncology KURA Stock Holding History

Covestor’s Portfolio KURA Stock Details KURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$0	Sell	26 -17	-40%	-$190	﹤0.01%	2616
2026 Q2	$0	Buy	43 +30	+231%	+$283	﹤0.01%	2674
2026 Q1	$0	Buy	13 +1	+8%	+$9	﹤0.01%	2540
2025 Q4	$0	Sell	12 -1	-8%	-$10	﹤0.01%	2510
2025 Q3	$0	Hold	13	–	–	﹤0.01%	2528
2025 Q2	$0	Sell	13 -1	-7%	-$6	﹤0.01%	2483
2025 Q1	$0	Buy	14 +8	+133%	+$62	﹤0.01%	2486
2024 Q4	$0	Hold	6	–	–	﹤0.01%	2495
2024 Q3	$0	Hold	6	–	–	﹤0.01%	2480
2024 Q2	$0	Hold	6	–	–	﹤0.01%	2498
2024 Q1	$0	Sell	6 -4	-40%	-$78	﹤0.01%	2497
2023 Q4	$0	Sell	10 -1	-9%	-$10	﹤0.01%	2432
2023 Q3	$0	Buy	11 +4	+57%	+$41	﹤0.01%	2414
2023 Q2	$0	Hold	7	–	–	﹤0.01%	2405
2023 Q1	$0	Hold	7	–	–	﹤0.01%	2314
2022 Q4	$0	Sell	7 -1	-13%	-$15	﹤0.01%	2339
2022 Q3	$0	Buy	+8	New	+$123	﹤0.01%	2307

Other funds holding KURA

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return

Jupiter Asset Management London, United Kingdom $21.4B AUM 19.74% 1-Year Est. Return

Nan Fung Trinity Central, Hong Kong, Hong Kong $1.04B AUM 32.17% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $57.2B AUM 42.49% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Royce & Associates New York $11B AUM 39.4% 1-Year Est. Return

Covestor's KURA Position: Q3 2026 in Review

Covestor reduced its Kura Oncology (KURA) stake by 40% in Q3 2026, selling an estimated $190 and leaving 26 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2616.

Covestor first reported a position in KURA in Q3 2022 and has held it in 17 quarters since. 138 funds tracked by Wall St. Rank hold KURA as of Q3 2026.

Covestor held 26 shares of Kura Oncology worth $0 as of Q3 2026.
Covestor sold 17 Kura Oncology shares in Q3 2026, an estimated $190.
Kura Oncology made up ﹤0.01% of Covestor's portfolio in Q3 2026, its #2616 holding.
Covestor first reported a position in Kura Oncology in Q3 2022 and has held it in 17 quarters since.
138 funds tracked by Wall St. Rank held Kura Oncology as of Q3 2026.

Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.